Chemo timing and the menstrual cycle in breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests whether the timing of chemotherapy during your menstrual cycle affects how well it works in triple-negative breast cancer. Women with regular periods who are about to start chemo before surgery may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and younger than 60.
- You have just been diagnosed with triple-negative breast cancer that is stage I, II, or III, or cancer that came back in the same area (but not spread far away).
- You have not started any breast cancer treatment yet (no chemo, hormone therapy, or targeted therapy).
- You have regular monthly periods (not on hormonal birth control like the pill, IUD, or implant).
- You are willing to receive chemotherapy before surgery (neoadjuvant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how breast cancer changes while you are receiving chemotherapy or targeted therapy before surgery. The goal is to better understand which treatments work best for different types of breast cancer.
This study tests whether some patients with early-stage, hormone-positive breast cancer can safely skip chemotherapy and just use hormone therapy plus a CDK4/6 inhibitor pill after surgery. If you qualify, you may avoid chemo side effects while still reducing the chance of the cancer coming back.
This trial tests whether a special cycling exercise program during chemotherapy can help women with breast cancer. It is for patients who are about to start a common type of chemotherapy and want to add physical activity to their treatment plan.
This trial compares two different chemotherapy combinations given before surgery (neoadjuvant therapy) for people with triple-negative breast cancer. It looks to see which drug combination works better to control the cancer before and around the time of the operation.
This study compares taking a daily pill (dalpiciclib with hormone therapy) versus standard chemotherapy before breast cancer surgery. It's for postmenopausal women with a common type of early breast cancer that is strongly hormone-receptor positive and HER2-negative.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.